EXHIBIT 99.1
Published on July 14, 2016
Exhibit 99.1
VIA SEDAR
July 14, 2016
Autorité des marchés financiers
Alberta Securities Commission
British Columbia Securities Commission
Manitoba Securities Commission
Ontario Securities Commission
| Subject: | Acasti Pharma inc. (the “Corporation”) | |
| Report on the Voting Results, in accordance with article 11.3 of Regulation 51-102 respecting Continuous Disclosure Obligations (“Regulation 51-102”) |
Following the annual and special meeting of shareholders of the Corporation held on July 12, 2016 (the “AGM”), this report presents the items voted on during the AGM and the corresponding voting results, in accordance with article 11.3 of Regulation 51-102. For more detailed information on the proposals submitted to shareholders, please refer to the Proxy Management Circular of the Corporation dated June 14, 2016 (the “Circular”).
According to the scrutineers reports, being present in person or by proxy, were the holders of 6,693,736 common shares, or 62.49%, of the 10,712,038 common shares issued and outstanding on May 31, 2016, the record date for the AGM.
| 1. | Election of the directors of the Corporation for the ensuring year |
| Votes in Favor | % In Favor | Votes Withheld | % Withheld | |
|
Jean-Marie (John) Canan
|
5,592,689 | 99.79% | 11,738 | 0.21% |
|
Roderick N. Carter
|
5,592,417 | 99.79% | 12,010 | 0.21% |
|
Janelle D’Alvise
|
5,597,512 | 99.88% | 6,915 | 0.12% |
|
James S. Hamilton
|
5,596,128 | 99.85% | 8,299 | 0.15% |
|
Leendert H. Staal
|
5,597,562 | 99.88% | 6,865 | 0.12% |
| 2. | Appointment of KPMG LLP as auditors for the ensuing year and to authorize the directors of the Corporation to fix their remuneration |
| Votes in Favor | % In Favor | Votes Withheld | % Withheld |
| 6,602,471 | 99.38% | 41,208 | 0.62% |
1 of 2
| 3. | Ordinary resolution to approve certain amendments to the Corporation’s stock option plan, as previously approved by the board of directors of the Corporation (the “Board”), as more particularly described in the accompanying Circular |
| Votes in Favor | % In Favor | Votes Against | % Against |
| 5,437,680 | 98.88% | 61,850 | 1.12% |
| 4. | Ordinary resolution to approve the grant of 525,000 options to purchase common shares of the Corporation, as previously approved by the Board, as more particularly described in the Circular |
| Votes in Favor | % In Favor | Votes Against | % Against |
| 5,549,295 | 99.02% | 55,132 | 0.98% |
| 5. | Ordinary resolution to approve certain amendments to the Corporation’s equity incentive plan, as more particularly described in the Circular |
| Votes in Favor | % In Favor | Votes Against | % Against |
| 5,440,251 | 98.92% | 59,279 | 1.08% |
Sincerely,
| /s/ Jean-Daniel Bélanger |
Jean-Daniel Bélanger
Director, Corporate Affairs and Corporate Secretary
2 of 2